Patent details
300163
Product Name:
Efalizumab
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300163
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP0941344
Status:
Expired Art. 14 (a) of the EC Regulations
Application number:
300163
Procedural language:
Dutch
First Applicant Residence Country:
Marketing Authorization
1
Marketing Authorization Number:
56714
Marketing Authorization Type:
EEA
Marketing Authorization Date:
09/03/2004
Marketing Authorization Country:
Switzerland (CH)
2
Marketing Authorization Number:
EU/1/04/291/001
Marketing Authorization Type:
EEA
Marketing Authorization Date:
20/09/2004
Marketing Authorization Country:
European Union (EU)
3
Marketing Authorization Number:
EU/1/04/291/002
Marketing Authorization Type:
EEA
Marketing Authorization Date:
20/09/2004
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
12/11/2004
First Marketing Authorization date:
09/03/2004
Grant date:
26/04/2005
Activation date:
20/10/2017
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
12/11/2004
SPC/SPC Extension Expiration Date:
08/03/2019
Lapsed By Expiration Date:
09/03/2019
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
12/11/2004
Name:
Genentech, Inc.
Address:
1 DNA Way, 94080-4990, South San Francisco, California, United States of America (US)
Agent
Name:
ir. M.F.J.M. Ketelaars c.s.
From:
12/11/2004
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
11/19
Publication date:
13/03/2019
Description:
Lapse or annulment
2
Bulletin Heading:
SPC
Journal edition number:
43/17
Publication date:
25/10/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
Bulletin Heading:
SPC
Journal edition number:
2005/07
Publication date:
01/07/2005
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
4
Bulletin Heading:
SPC
Journal edition number:
2005/01
Publication date:
03/01/2005
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Annual Fee
Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
28/09/2018
Last Annual Fee Paid Number:
22
Last Annual Fee Paid Amount:
1800 Euro
Payer:
Master Data Center
Filing date
Document type
Document Description
Number of pages
File Type
26/04/2005
Outgoing Correspondence
Outgoing Letter
1
PDF
/3/6/1/0/0/0400300163/docs/300163_1_outgoingcorrespondence20050426.pdf
26/04/2005
Outgoing Correspondence
Outgoing Letter
1
PDF
/3/6/1/0/0/0400300163/docs/300163_7_outgoingcorrespondence20050426.pdf
20/11/2004
General
4
PDF
/3/6/1/0/0/0400300163/docs/300163_0_spc-documents20041120.pdf
20/11/2004
Outgoing Correspondence
Outgoing Letter
1
PDF
/3/6/1/0/0/0400300163/docs/300163_2_outgoingcorrespondence20041120.pdf
20/11/2004
General
11
PDF
/3/6/1/0/0/0400300163/docs/300163_3_spc-documents20041120.pdf
12/11/2004
General
4
PDF
/3/6/1/0/0/0400300163/docs/300163_4_spc-documents20041112.pdf
12/11/2004
General
16
PDF
/3/6/1/0/0/0400300163/docs/300163_5_spc-documents20041112.pdf
12/11/2004
Application Form
First filed application form
2
PDF
/3/6/1/0/0/0400300163/docs/300163_6_applicationform20041112.pdf
12/11/2004
General
2
PDF
/3/6/1/0/0/0400300163/docs/300163_8_spc-documents20041112.pdf